Source: Eur Respir J, 53 (1) 1801030; 10.1183/13993003.01030-2018
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Stephanie Law, Amrita Daftary, Max O'Donnell, Nesri Padayatchi, Liviana Calzavara, Dick Menzies. Interventions to improve retention-in-care and treatment adherence among patients with drug-resistant tuberculosis: a systematic review. Eur Respir J, 53 (1) 1801030; 10.1183/13993003.01030-2018

Member's Comments

No comment yet.

Related content which might interest you: Epidemiology and clinical management of XDR-TB: a systematic review by TBNET Source: Eur Respir J 2009; 33: 871-881 Year: 2009 Effectiveness of interventions for reducing TB incidence in countries with low TB incidence: a systematic review of reviews Source: Eur Respir Rev, 28 (152) 180107; 10.1183/16000617.0107-2018 Year: 2019 Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018 Effectiveness of community-based self-management interventions among primary care COPD patients: a systematic review Source: International Congress 2017 – Primary care management of asthma and self-management of respiratory disease Year: 2017 Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review Source: Eur Respir J, 52 (1) 1800934; 10.1183/13993003.00934-2018 Year: 2018 WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update Source: Eur Respir J 2011; 38: 516-528 Year: 2011 Design of tuberculosis treatment regimens for drug-resistant and intolerant patients – patient and clinician perspectives Source: International Congress 2018 – CC4 Tuberculosis Year: 2018 Getting the best possible evidence from observational studies of treatment of multidrug-resistant tuberculosis patients Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights Year: 2013 Prevalence of inappropriate tuberculosis treatment regimens: a systematic review Source: Eur Respir J 2012; 39: 1012-1020 Year: 2012 Treatment interruptions in patients with MDR/XDR-TB: risk factors and impact on treatment outcomes Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016 Home-based pulmonary rehabilitation and follow-up strategies in COPD patients: a systematic review Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases Year: 2019 Mycobacterium tuberculosis transmission from patients with drug-resistant compared to drug-susceptible TB: a systematic review and meta-analysis Source: Eur Respir J, 50 (4) 1701044; 10.1183/13993003.01044-2017 Year: 2017 Microscopic observation drug susceptibility assay for the diagnosis of TB and MDR-TB in HIV-infected patients: a systematic review and meta-analysis Source: Eur Respir J 2014; 44: 973-984 Year: 2014 The safety of isoniazid tuberculosis preventive treatment in pregnant and postpartum women: systematic review and meta-analysis Source: Eur Respir J, 55 (3) 1901967; 10.1183/13993003.01967-2019 Year: 2020 Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study Source: Eur Respir J 2001; 18: 369-375 Year: 2001 Monitoring toxicity in individuals receiving treatment for latent tuberculosis infection: a systematic review versus expert opinion Source: Eur Respir J 2015; 45: 1170-1173 Year: 2015 Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of multidrug-resistant tuberculosis Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016 Predictors of defaulting from treatment among patients with tuberculosis Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 Bedaquiline-containing regimens for MDR TB treatment – Focus on the safety Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016